AGP Executive Report
Last update: 2 hours agoMedicare: Open enrollment began Oct. 15, but about 3.2 million Medicare Advantage members must find new coverage for 2027. Part D’s out-of-pocket cap will rise to $2,400, and a temporary premium subsidy is ending. Cancer Treatment: EU regulators backed Revolution Medicines’ daraxonrasib for metastatic pancreatic cancer, a step toward possible marketing authorization. Medical Debt: Illinois says its relief program has erased more than $2.4 billion owed by 1.5 million residents. Drug Safety: CVS agreed to pay $315 million to resolve claims that its pharmacies filled unlawful opioid prescriptions, including risky combinations. Medicaid Oversight: CMS now has authority to exclude providers linked to fraud from Medicare and Medicaid.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
